Challenges of Conducting a Placebo-Controlled Trial for Dysmenorrhea in Adolescents

Journal of Adolescent Health

Volumn 39, Issue 4, 2006, Pages 607-609

  Davis, Anne R ^a   Osborne, Lauren M ^a   O'Connell, Katharine J ^a   Westhoff, Carolyn L ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adolescents; Dysmenorrhea; Oral contraception

Indexed keywords

ORAL CONTRACEPTIVE AGENT; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DYSMENORRHEA; FEMALE; HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEXUAL BEHAVIOR; TREATMENT WITHDRAWAL;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; CHILD; CONTRACEPTIVES, ORAL; DYSMENORRHEA; FEMALE; HUMANS; PATIENT COMPLIANCE; SEXUAL ABSTINENCE;

EID: 33748524875     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2006.03.019     Document Type: Article

References (16)

1. U.S. Congress, Office of Technology Assessment. Adolescent Health-Volume I: Summary and Policy Options (OTA-H-468) (1991), U.S. Government Printing Office, Washington, DC
2. Santelli J.S., Rosenfeld W.D., DuRant R.H., et al. Guidelines for adolescent health research: A position paper of the society for adolescent medicine. J Adolesc Health 17 (1995) 270-276
3. Redmond G.P., Olson W.H., Lippman J.S., et al. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 89 (1997) 615-622
4. Davis A., Godwin A., Lippman J., et al. Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding. Obstet Gynecol 96 (2000) 913-920
5. Thiboutot D., Archer D.F., Lemay A., et al. A randomized controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol; and 100 μg of levonorgestrel for acne treatment. Fertil Steril 76 3 (2001) 461-468
6. Davis A.R., Westhoff C., O'Connell K., and Gallagher N. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized, placebo-controlled trial. Obstet Gynecol 106 (2005) 97-104
7. Herold E., and Goodwin M. Perceived side effects of oral contraceptives among adolescent girls. Can Med Assoc J 123 (1980) 1022-1026
8. Peipert J.F., and Gutmann J. Oral contraceptive risk assessment: a survey of 247 educated women. Obstet Gynecol 82 1 (1993) 112-117
9. Tessler S.L., and Peipert J.F. Perceptions of contraceptive effectiveness and health effects of oral contraception. Womens Health Issues 7 6 (1997) 400-406
10. Cramer A.J. Compliance with contraceptives and other treatments. Obstet Gynecol 88 (1996) 4S-12S
11. Emans S.J., Grace E., Woods E.R., et al. Adolescents' compliance with the use of oral contraceptives. JAMA 257 (1987) 3377-3381
12. Rosenberg M.J., and Waugh M.S. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179 (1998) 577-582
13. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control. 2003 Youth Risk Behavior Survey. Available from: http://apps.nccd.cdc.gov/yrbss.
14. Frost JJ, Jones RK, Woog V, et al. Teenage sexual and reproductive behavior in developed countries: country report for the United States. Occasional Report No. 8, November 2001, The Alan Guttmacher Institute. Tables A5, A7.
15. Kaiser Family Foundation, Hoff T., Greene L., and Davis J. National Survey of Adolescents and Young Adults: Sexual Health Knowledge, Attitudes, and Experiences (2003), Henry Kaiser Family Foundation, Menlo Park, CA
16. Davis A.R., and Westhoff C.L. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 14 (2001) 3-8